Nuveen’s Pfizer PFE Stock Holding History

Nuveen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,800	Closed	-$4K	–	3393
2021 Q3	$4K	Buy	+100,800	New	+$4.47M	﹤0.01%	3391

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen's PFE Position: Q2 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 9.6% in Q2 2026, buying an estimated $33.1M and bringing the position to 14,445,787 shares worth $348M. The position accounts for 0.08% of the portfolio, ranked #181.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.66B in Q4 2021. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Nuveen held 14,445,787 shares of Pfizer worth $348M as of Q2 2026.
Nuveen bought 1,267,126 Pfizer shares in Q2 2026, an estimated $33.1M.
Pfizer made up 0.08% of Nuveen's portfolio in Q2 2026, its #181 holding.
Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.